IM Cannabis Corp. reported its Q2 2023 financial results, with a 4% YoY increase in revenue to CA$13.2 million. Gross profit increased by 57% YoY to CA$3.5 million, while operating loss decreased by 69% YoY. The company's CEO, Oren Shuster, highlighted strategic decisions that led to 'sustainable profitability'. Shuster also praised the anticipated reform of medical cannabis regulations in Israel, which is expected to reduce industry restrictions. IMC's shares traded 15.3153% lower at $0.94 per share on Tuesday morning.